Biased β2‐adrenoceptor signalling in heart failure: pathophysiology and drug discovery

No abstract is available for this paper.

• Publication year

  2015

• Venue

  British Journal of Pharmacology

• Publication date

  2015-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bph.12965PMID 25298054PMCID PMC4667850
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tyrosine 308 Is Necessary for Ligand-directed Gs Protein-biased Signaling of β2-Adrenoceptor*

  2014cited by this paper
• Caveolin-3 regulates compartmentation of cardiomyocyte beta2-adrenergic receptor-mediated cAMP signaling.

  2014cited by this paper
• Deletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice.

  2013cited by this paper
• Epac2 Mediates Cardiac &bgr;1-Adrenergic–Dependent Sarcoplasmic Reticulum Ca2+ Leak and Arrhythmia

  2013cited by this paper
• The Concise Guide to Pharmacology 2013/14: Enzymes

  2013cited by this paper
• The Concise Guide to Pharmacology 2013/14: Catalytic Receptors

  2013cited by this paper
• The Concise Guide to Pharmacology 2013/14: Nuclear Hormone Receptors

  2013cited by this paper
• Novel rat model reveals important roles of β-adrenoreceptors in stress-induced cardiomyopathy.

  2013influential reference
• Faculty Opinions recommendation of High levels of circulating epinephrine trigger apical cardiodepression in a β2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy.

  2013cited by this paper
• The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors

  2013cited by this paper
• Spatial control of the βAR system in heart failure: the transverse tubule and beyond.

  2013cited by this paper
• The functional activity of inhibitory G protein (G(i)) is not increased in failing heart ventricle.

  2013cited by this paper
• Functional subcellular distribution of β1- and β2-adrenergic receptors in rat ventricular cardiac myocytes

  2013cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

  2013cited by this paper
• National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011

  2013cited by this paper
• Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias.

  2012cited by this paper
• β-Adrenergic receptor subtype signaling in heart: From bench to bedside

  2012cited by this paper
• High Levels of Circulating Epinephrine Trigger Apical Cardiodepression in a &bgr;2-Adrenergic Receptor/Gi–Dependent Manner: A New Model of Takotsubo Cardiomyopathy

  2012cited by this paper
• Targeting the &bgr;-Adrenergic Receptor System Through G-Protein–Coupled Receptor Kinase 2: A New Paradigm for Therapy and Prognostic Evaluation in Heart Failure From Bench to Bedside

  2012cited by this paper
• β‐Adrenergic receptor antagonists ameliorate myocyte T‐tubule remodeling following myocardial infarction

  2012cited by this paper
• Gi-Biased &bgr;2AR Signaling Links GRK2 Upregulation to Heart Failure

  2012cited by this paper
• Global status report on noncommunicable diseases 2010.

  2011cited by this paper
• GRK2 as a novel gene therapy target in heart failure.

  2011cited by this paper
• The Inotropic Peptide &bgr;ARKct Improves &bgr;AR Responsiveness in Normal and Failing Cardiomyocytes Through G&bgr;&ggr;-Mediated L-Type Calcium Current Disinhibition

  2011cited by this paper
• CaMKII in myocardial hypertrophy and heart failure.

  2011cited by this paper
• Gαs-Biased β2-Adrenergic Receptor Signaling from Restoring Synchronous Contraction in the Failing Heart

  2011cited by this paper
• Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective beta(2)-adrenergic receptor agonists.

  2010cited by this paper
• β-Arrestin–dependent activation of Ca2+/calmodulin kinase II after β1–adrenergic receptor stimulation

  2010cited by this paper
• Ryanodine Receptor Phosphorylation by Calcium/Calmodulin-Dependent Protein Kinase II Promotes Life-Threatening Ventricular Arrhythmias in Mice With Heart Failure

  2010cited by this paper
• Ligand‐directed signalling at β‐adrenoceptors

  2010cited by this paper
• β2-Adrenergic Receptor Redistribution in Heart Failure Changes cAMP Compartmentation

  2010cited by this paper
• Therapeutic potential of functional selectivity in the treatment of heart failure.

  2010cited by this paper
• Therapeutic Efficacy of a Combination of a β1-Adrenoreceptor (AR) Blocker and β2-AR Agonist in a Rat Model of Postmyocardial Infarction Dilated Heart Failure Exceeds That of a β1-AR Blocker plus Angiotensin-Converting Enzyme Inhibitor

  2009cited by this paper
• Loss of T-tubules and other changes to surface topography in ventricular myocytes from failing human and rat heart

  2009cited by this paper
• Agonist Dose-dependent Phosphorylation by Protein Kinase A and G Protein-coupled Receptor Kinase Regulates β2 Adrenoceptor Coupling to Gi Proteins in Cardiomyocytes*

  2009cited by this paper
• Stereochemistry of an Agonist Determines Coupling Preference of β2-Adrenoceptor to Different G Proteins in Cardiomyocytes

  2009cited by this paper
• A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy

  2009cited by this paper
• Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.

  2009cited by this paper
• Cardioprotective and Survival Benefits of Long-Term Combined Therapy with β2 Adrenoreceptor (AR) Agonist and β1 AR Blocker in Dilated Cardiomyopathy Postmyocardial Infarction

  2008cited by this paper
• G Protein-Coupled Receptor Kinase 2 Ablation in Cardiac Myocytes Before or After Myocardial Infarction Prevents Heart Failure

  2008cited by this paper
• Norepinephrine- and Epinephrine-induced Distinct β2-Adrenoceptor Signaling Is Dictated by GRK2 Phosphorylation in Cardiomyocytes*

  2008cited by this paper
• β-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivation

  2008cited by this paper
• Effects of clenbuterol on contractility and Ca2+ homeostasis of isolated rat ventricular myocytes.

  2008cited by this paper
• Arrhythmogenic Effects of &bgr;2-Adrenergic Stimulation in the Failing Heart Are Attributable to Enhanced Sarcoplasmic Reticulum Ca Load

  2008cited by this paper
• Expression of a Gi-coupled receptor in the heart causes impaired Ca2+ handling, myofilament injury, and dilated cardiomyopathy.

  2008cited by this paper
• Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection.

  2007cited by this paper
• GPCR functional selectivity has therapeutic impact.

  2007cited by this paper
• β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection

  2007cited by this paper
• β-Arrestin-biased ligands at seven-transmembrane receptors

  2007cited by this paper
• A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling

  2007cited by this paper
• Beta-arrestin-biased ligands at seven-transmembrane receptors.

  2007cited by this paper
• Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor.

  2007cited by this paper
• (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through β2-adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling

  2007cited by this paper
• A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling.

  2007cited by this paper
• Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors.

  2007cited by this paper
• Functional Selectivity and Classical Concepts of Quantitative Pharmacology

  2007cited by this paper
• CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy.

  2006cited by this paper
• Caveolae modulate excitation-contraction coupling and beta2-adrenergic signalling in adult rat ventricular myocytes.

  2006cited by this paper
• Trends in prevalence and outcome of heart failure with preserved ejection fraction.

  2006cited by this paper
• β2-Adrenergic stimulation is involved in the contractile dysfunction of the stunned heart

  2006cited by this paper
• Cyclic AMP Imaging in Adult Cardiac Myocytes Reveals Far-Reaching &bgr;1-Adrenergic but Locally Confined &bgr;2-Adrenergic Receptor–Mediated Signaling

  2006cited by this paper
• Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy.

  2006cited by this paper
• Level of beta-adrenergic receptor kinase 1 inhibition determines degree of cardiac dysfunction after chronic pressure overload-induced heart failure.

  2005cited by this paper
• Increased Nitration of Sarcoplasmic Reticulum Ca2+-ATPase in Human Heart Failure

  2005cited by this paper
• Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility.

  2005cited by this paper
• The role of beta-adrenergic receptor signaling in cardioprotection.

  2005cited by this paper
• G Protein Activation without Subunit Dissociation Depends on a Gαi-specific Region*

  2005cited by this paper
• Restoration of &bgr;-Adrenergic Receptor Signaling and Contractile Function in Heart Failure by Disruption of the &bgr;ARK1/Phosphoinositide 3-Kinase Complex

  2005cited by this paper
• Heart failure

  2005cited by this paper
• Pharmacological Stimulation of β 2-adrenergic Receptors (β 2AR) Enhances Therapeutic Effectiveness of β 1AR Blockade in Rodent Dilated Ischemic Cardiomyopathy

  2005cited by this paper
• The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly.

  2005cited by this paper
• G Protein activation without subunit dissociation depends on a G{alpha}(i)-specific region.

  2005cited by this paper
• The role of β‐Adrenergic Receptor Signaling in Cardioprotection

  2005cited by this paper
• Differential cardioprotective/cardiotoxic effects mediated by beta-adrenergic receptor subtypes.

  2005cited by this paper
• The Enigma of β2-Adrenergic Receptor Gi Signaling in the Heart: The Good, the Bad, and the Ugly

  2005cited by this paper
• Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy.

  2005cited by this paper
• Heterodimerization of β1- and β2-Adrenergic Receptor Subtypes Optimizes β-Adrenergic Modulation of Cardiac Contractility

  2005cited by this paper
• Level of &bgr;-Adrenergic Receptor Kinase 1 Inhibition Determines Degree of Cardiac Dysfunction After Chronic Pressure Overload–Induced Heart Failure

  2005cited by this paper
• Loss of beta-adrenoceptor response in myocytes overexpressing the Na+/Ca(2+)-exchanger.

  2004cited by this paper
• Sustained beta1-adrenergic stimulation modulates cardiac contractility by Ca2+/calmodulin kinase signaling pathway.

  2004cited by this paper
• Beneficial Effects of Chronic Pharmacological Manipulation of &bgr;-Adrenoreceptor Subtype Signaling in Rodent Dilated Ischemic Cardiomyopathy

  2004cited by this paper
• Reduced synchrony of Ca2+ release with loss of T-tubules-a comparison to Ca2+ release in human failing cardiomyocytes.

  2004cited by this paper
• Loss of β-adrenoceptor response in myocytes overexpressing the Na+/Ca2+-exchanger

  2004cited by this paper
• Na+/Ca2+ exchange linking beta2-adrenergic G(i) signaling to heart failure: associated defect of adrenergic contractile support.

  2004cited by this paper
• Protecting the myocardium: A role for the &bgr;2 adrenergic receptor in the heart

  2004cited by this paper
• Na+/Ca2+ exchange linking beta2-adrenergic G(i) signaling to heart failure: associated defect of adrenergic contractile support.

  2004cited by this paper
• Sustained &bgr;1-Adrenergic Stimulation Modulates Cardiac Contractility by Ca2+/Calmodulin Kinase Signaling Pathway

  2004cited by this paper
• β1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure

  2003cited by this paper
• Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II.

  2003cited by this paper
• Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure.

  2003cited by this paper
• Enhanced Gi Signaling Selectively Negates &bgr;2-Adrenergic Receptor (AR)– but Not &bgr;1-AR–Mediated Positive Inotropic Effect in Myocytes From Failing Rat Hearts

  2003cited by this paper
• Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

  2003cited by this paper
• Specific β2AR Blocker ICI 118,551 Actively Decreases Contraction Through a Gi-Coupled Form of the β2AR in Myocytes From Failing Human Heart

  2002cited by this paper
• Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart.

  2002cited by this paper
• Calmodulin Kinase II and Arrhythmias in a Mouse Model of Cardiac Hypertrophy

  2002cited by this paper
• Long-term use of a left ventricular assist device for end-stage heart failure.

  2001cited by this paper
• Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes.

  2001cited by this paper
• Reduction in density of transverse tubules and L-type Ca(2+) channels in canine tachycardia-induced heart failure.

  2001cited by this paper
• Effect of carvedilol on survival in severe chronic heart failure.

  2001cited by this paper
• The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase.

  2000cited by this paper

• Assessment of the myocardial beta‑adrenergic activity in patients with chronic coronary artery disease with preserved and reduced left ventricular ejection fraction and the need for inotropic support after coronary artery bypass grafting

  2026cites this paper
• Biased Agonism at β-Adrenoceptor Subtypes: A Drug Development Perspective.

  2025cites this paper
• Adrenoceptors in GtoPdb v.2025.3

  2025cites this paper
• The beta1-adrenergic receptor in the heart

  2025cites this paper
• Implication of Central β2 Adrenergic Receptor for the Development of Novel Drugs Against Alzheimer's Disease

  2025cites this paper
• Canonical or non‐canonical, all aspects of G protein‐coupled receptor kinase 2 in heart failure

  2025cites this paper
• Biased GPCR Signaling: Possible Mechanisms and Therapeutic Applications.

  2025cites this paper
• Molecular insights into G protein coupling specificity at a class A GPCR

  2024cites this paper
• Structure and dynamics determine G protein coupling specificity at a class A GPCR

  2024cites this paper
• Roles of β-adrenoceptor Subtypes and Therapeutics in Human Cardiovascular Disease: Heart Failure, Tachyarrhythmias and Other Cardiovascular Disorders.

  2024cites this paper
• The influence of low-intensity laser radiation on the blood parameters of cows under technological stress

  2023cites this paper
• Cardiac Adrenergic Receptors and GRKs: Mitochondrial Modulation in the Heart

  2023cites this paper
• Status of β1-Adrenoceptor Signal Transduction System in Cardiac Hypertrophy and Heart Failure

  2023cites this paper
• Association among β2‐adrenergic receptor autoantibodies and proximal left anterior descending artery lesions in patients with initial ST‐segment elevation myocardial infarction

  2023cites this paper
• Functional LTCC-β2AR Complex Needs Caveolin-3 and Is Disrupted in Heart Failure

  2023cites this paper
• Identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics

  2023cites this paper
• Adrenergic Receptor Regulation of Mitochondrial Function in Cardiomyocytes

  2022cites this paper
• QR code model: a new possibility for GPCR phosphorylation recognition

  2022cites this paper
• Cardiac β-Adrenoceptor Signaling: The New Insight on An Old Target in the Therapy of Cardiovascular Disease

  2022cites this paper
• Adrenoceptor sub-type involvement in Ca2+ current stimulation by noradrenaline in human and rabbit atrial myocytes

  2022cites this paper
• Risk factors for a broken heart: understanding drug-induced causes for Takotsubo syndrome and pharmacological treatment options

  2022cites this paper
• Computational characterization of transducer recognition of β2 adrenergic receptor.

  2022cites this paper
• Biased activation of β2-AR/Gi/GRK2 signal pathway attenuated β1-AR sustained activation induced by β1-adrenergic receptor autoantibody

  2021cites this paper
• GRKs and Epac1 Interaction in Cardiac Remodeling and Heart Failure

  2021cites this paper
• Amino terminal recognition by a CCR6 chemokine receptor antibody blocks CCL20 signaling and IL-17 expression via β-arrestin

  2021cites this paper
• Single Nuclei Sequencing Reveals Novel Insights Into the Regulation of Cellular Signatures in Children With Dilated Cardiomyopathy

  2021cites this paper
• Membrane Proteins | L-Type Calcium Channels in Health and Disease: The Case of Heart Failure

  2020cites this paper
• Androgen Effects on the Adrenergic System of the Vascular, Airway, and Cardiac Myocytes and Their Relevance in Pathological Processes

  2020cites this paper
• An Electrocardiographic and Morphological Study of Oral L-Arginine Administration Effects on a Model of Cardiotoxicβ2 Overstimulation

  2020cites this paper
• β2-adrenoceptor modulation in COPD and its potential impact on cardiovascular comorbidities

  2020cites this paper
• Role of β2-adrenergic receptors in chronic obstructive pulmonary disease.

  2020cites this paper
• The role of β-adrenergic system remodeling in human heart failure: A mechanistic investigation.

  2020cites this paper
• Hybridization of β-Adrenergic Agonists and Antagonists Confers G Protein Bias.

  2019cites this paper
• The role of GPCR signaling in cardiac Epithelial to Mesenchymal Transformation (EMT).

  2019cites this paper
• Discovery of β-arrestin-biased β2-adrenoceptor agonists from 2-amino-2-phenylethanol derivatives

  2019cites this paper
• PKA/β2-AR-Gs/Gi signaling pathway is associated with anti-inflammatory and pro-apoptotic effects of Fuzi and Banxia combination on rats subjected to pressure overload.

  2019cites this paper
• Metabolic effects of epinephrine on the crab Neohelice granulata.

  2019cites this paper
• Cardiac β3‐adrenoceptors—A role in human pathophysiology?

  2019cites this paper
• Ca2+/Calmodulin-Dependent Protein Kinase II Regulation by Inhibitor 1 of Protein Phosphatase 1 Protects Against Myocardial Ischemia–Reperfusion Injury

  2019cites this paper
• Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential.

  2019cites this paper
• Local membrane charge regulates β2 adrenergic receptor coupling to Gi3

  2019cites this paper
• Beta-blockers: Historical perspective and mechanisms of action.

  2019cites this paper
• Paper : The Effect of Self-Care Education on the Resilience of the Patients With Heart Failure

  2019cites this paper
• Adrenoceptor regulation of the mechanistic target of rapamycin in muscle and adipose tissue

  2019cites this paper
• Title : Adrenoceptor regulation of mTOR in muscle and adipose tissue Running title : Metabolic effects of mTOR in adrenoceptor signaling

  2019cites this paper
• Integrating Pharmacokinetics Study, Network Analysis, and Experimental Validation to Uncover the Mechanism of Qiliqiangxin Capsule Against Chronic Heart Failure

  2019cites this paper
• Bloqueadores beta: perspectiva histórica y mecanismos de acción

  2019cites this paper
• Upregulation of β3-adrenoceptors—a general marker of and protective mechanism against hypoxia?

  2019cites this paper
• Correspondence: Reply to ‘Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury’

  2018cites this paper
• Local membrane charge regulates ல2 adrenergic receptor coupling to Gi

  2018cites this paper
• Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin

  2018cites this paper
• Fuzi and Banxia Combination, Eighteen Antagonisms in Chinese Medicine, Aggravates Adriamycin-Induced Cardiomyopathy Associated with PKA/β2AR-Gs Signaling

  2018cites this paper
• Dihydromyricetin Attenuates Myocardial Hypertrophy Induced by Transverse Aortic Constriction via Oxidative Stress Inhibition and SIRT3 Pathway Enhancement

  2018cites this paper
• The Application of Dynamic Models to the Exploration of β1-AR Overactivation as a Cause of Heart Failure

  2018cites this paper
• Alteration of β-Adrenoceptor Signaling in Left Ventricle of Acute Phase Takotsubo Syndrome: a Human Study

  2018cites this paper
• Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.

  2018cites this paper
• Ginseng Compatibility Environment Attenuates Toxicity and Keeps Efficacy in Cor Pulmonale Treated by Fuzi Beimu Incompatibility Through the Coordinated Crosstalk of PKA and Epac Signaling Pathways

  2018cites this paper
• &bgr;2‐Adrenoceptor signalling bias in asthma and COPD and the potential impact on the comorbidities associated with these diseases

  2018cites this paper
• Stage-dependent changes of β2-adrenergic receptor signaling in right ventricular remodeling in monocrotaline-induced pulmonary arterial hypertension

  2018cites this paper
• Hemodynamic Effects of Glucagon: A Literature Review

  2018cites this paper
• IL-18 cleavage triggers cardiac inflammation and fibrosis upon &bgr;-adrenergic insult

  2018cites this paper
• Biased Agonism at the Angiotensin Receptor: Blocker and Calcium Sensitizer at the Same Time

  2017cites this paper
• Role of Beta-adrenergic Receptors and Sirtuin Signaling in the Heart During Aging, Heart Failure, and Adaptation to Stress

  2017cites this paper
• Alpha2-adrenoceptors in adrenomedullary chromaffin cells: functional role and pathophysiological implications

  2017cites this paper
• Insulin and β Adrenergic Receptor Signaling: Crosstalk in Heart.

  2017cites this paper
• Adrenergic Receptors in Individual Ventricular Myocytes: The Beta-1 and Alpha-1B Are in All Cells, the Alpha-1A Is in a Subpopulation, and the Beta-2 and Beta-3 Are Mostly Absent.

  2017cites this paper
• Adrenergic Receptors in Individual Ventricular Myocytes The Beta-1 and Alpha-1B Are in All Cells, the Alpha-1A Is in a Subpopulation, and the Beta-2 and Mostly Absent

  2017cites this paper
• A heart–brain–kidney network controls adaptation to cardiac stress through tissue macrophage activation

  2017cites this paper
• cAMP-PKA-CaMKII signaling pathway is involved in aggravated cardiotoxicity during Fuzi and Beimu Combination Treatment of Experimental Pulmonary Hypertension

  2016cites this paper
• The influence of adrenaline on contractility and excitability of myocardium of rat right ventricle depending on phases of the estrous cycle and pregnancy

  2016cites this paper
• Pathway for Sympathetic Cardioprotection in Heart Failure.

  2015cites this paper
• A New Pathway for Sympathetic Cardioprotection in Heart Failure.

  2015cites this paper
• Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2‐adrenoceptor

  2015cites this paper
• Chinese innovation in cardiovascular drug discovery

  2015cites this paper